<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>Halloran Consulting Group, Inc.</title>
	<atom:link href="http://hallorancg.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://hallorancg.wordpress.com</link>
	<description>We are committed to transforming the process by which drugs, biologics, medical devices, and diagnostics are developed and brought to patients.</description>
	<lastBuildDate>Mon, 20 Sep 2010 19:36:47 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='hallorancg.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://0.gravatar.com/blavatar/451a550687085c3cdbd9c04af927d9ad?s=96&#038;d=http%3A%2F%2Fs2.wp.com%2Fi%2Fbuttonw-com.png</url>
		<title>Halloran Consulting Group, Inc.</title>
		<link>http://hallorancg.wordpress.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://hallorancg.wordpress.com/osd.xml" title="Halloran Consulting Group, Inc." />
	<atom:link rel='hub' href='http://hallorancg.wordpress.com/?pushpress=hub'/>
		<item>
		<title>FDA&#8217;s dilemma over Avastin</title>
		<link>http://hallorancg.wordpress.com/2010/09/20/fdas-dilemma-over-avastin/</link>
		<comments>http://hallorancg.wordpress.com/2010/09/20/fdas-dilemma-over-avastin/#comments</comments>
		<pubDate>Mon, 20 Sep 2010 19:36:47 +0000</pubDate>
		<dc:creator>hcginc</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hallorancg.wordpress.com/?p=97</guid>
		<description><![CDATA[FDA was expected to announce a decision on September 17,2010 about whether Roche&#8217;s (Genentech, US) top-selling cancer drug Avastin ($6 billion global sales last year) would remain on the U.S. market for the indication of advanced breast cancer.  Instead, FDA announced 3 months of additional review time to look at newly submitted clinical information by [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hallorancg.wordpress.com&amp;blog=10147292&amp;post=97&amp;subd=hallorancg&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hallorancg.wordpress.com/2010/09/20/fdas-dilemma-over-avastin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/15e35bd26a7cd42a739e615185661415?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hcginc</media:title>
		</media:content>
	</item>
		<item>
		<title>Are overstated marketing claims higher on FDA&#8217;s radar?</title>
		<link>http://hallorancg.wordpress.com/2010/09/02/are-overstated-marketing-claims-higher-on-fdas-radar/</link>
		<comments>http://hallorancg.wordpress.com/2010/09/02/are-overstated-marketing-claims-higher-on-fdas-radar/#comments</comments>
		<pubDate>Thu, 02 Sep 2010 13:54:06 +0000</pubDate>
		<dc:creator>hcginc</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hallorancg.wordpress.com/?p=89</guid>
		<description><![CDATA[While it is not uncommon for pharmaceutical companies to overstate the efficacy of their products and downplay serious side effects, FDA is now taking a strong stance; stronger than just issuing warning letters &#8212; a possibility of &#8220;stern FDA regulatory action, including seizure or injunction, without further notice.&#8221; This strict warning was recently given to Baxter [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hallorancg.wordpress.com&amp;blog=10147292&amp;post=89&amp;subd=hallorancg&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hallorancg.wordpress.com/2010/09/02/are-overstated-marketing-claims-higher-on-fdas-radar/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/15e35bd26a7cd42a739e615185661415?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hcginc</media:title>
		</media:content>
	</item>
		<item>
		<title>Is FDA starting to crack down on post-marketing commitments?  What does this means for the industry?</title>
		<link>http://hallorancg.wordpress.com/2010/08/17/is-fda-starting-to-crack-down-on-post-marketing-commitments-and-what-this-means-for-the-industry/</link>
		<comments>http://hallorancg.wordpress.com/2010/08/17/is-fda-starting-to-crack-down-on-post-marketing-commitments-and-what-this-means-for-the-industry/#comments</comments>
		<pubDate>Tue, 17 Aug 2010 18:36:13 +0000</pubDate>
		<dc:creator>hcginc</dc:creator>
				<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Regulatory]]></category>

		<guid isPermaLink="false">http://hallorancg.wordpress.com/?p=76</guid>
		<description><![CDATA[FDA proposes to remove Shire Low Blood Pressure drug from the market Shire&#8217;s low blood pressure drug, ProAmatine, along with its 5 generic forms (by: Apotex Corp., Impax Laboratories Inc., Mylan Pharmaceuticals, Sandoz Inc., and Upsher-Smith Laboratories) are being considered for withdrawal by the FDA after the companies failed to show any follow-up data, despite receiving [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hallorancg.wordpress.com&amp;blog=10147292&amp;post=76&amp;subd=hallorancg&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hallorancg.wordpress.com/2010/08/17/is-fda-starting-to-crack-down-on-post-marketing-commitments-and-what-this-means-for-the-industry/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/15e35bd26a7cd42a739e615185661415?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hcginc</media:title>
		</media:content>
	</item>
		<item>
		<title>The Drug Development World According to Pfizer&#8217;s Global Head of Policy</title>
		<link>http://hallorancg.wordpress.com/2010/05/18/the-drug-development-world-according-to-pfizers-global-head-of-policy/</link>
		<comments>http://hallorancg.wordpress.com/2010/05/18/the-drug-development-world-according-to-pfizers-global-head-of-policy/#comments</comments>
		<pubDate>Wed, 19 May 2010 04:01:23 +0000</pubDate>
		<dc:creator>lhalloran</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hallorancg.wordpress.com/?p=59</guid>
		<description><![CDATA[Had a delightful dinner last night with Greg Simon, Global Head of Policy at Pfizer. Some meaningful thoughts he had. I&#8217;m summarizing, and mostly quoting a snippet that had meaning for me. Greg: I was on the (Obama&#8217;s) FDA transition team, we interviewed people who have worked with FDA since 80s, we were in a [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hallorancg.wordpress.com&amp;blog=10147292&amp;post=59&amp;subd=hallorancg&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hallorancg.wordpress.com/2010/05/18/the-drug-development-world-according-to-pfizers-global-head-of-policy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/07bed0a792fa8e453dacc3ad858c5ef3?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Laurie H.</media:title>
		</media:content>
	</item>
		<item>
		<title>Welcome!</title>
		<link>http://hallorancg.wordpress.com/2009/10/28/hello-world/</link>
		<comments>http://hallorancg.wordpress.com/2009/10/28/hello-world/#comments</comments>
		<pubDate>Wed, 28 Oct 2009 01:30:00 +0000</pubDate>
		<dc:creator>hcginc</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Halloran Consulting Group has a mission: To teach, lead, and empower our clients with practical solutions and expert advice on efficient and effective use of resources to successfully manage and accelerate the development of life-improving and life-saving therapies. To design, develop and implement appropriate infrastructure that optimizes our clients&#8217; development processes while maintaining compliance with [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hallorancg.wordpress.com&amp;blog=10147292&amp;post=1&amp;subd=hallorancg&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hallorancg.wordpress.com/2009/10/28/hello-world/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/15e35bd26a7cd42a739e615185661415?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hcginc</media:title>
		</media:content>
	</item>
	</channel>
</rss>
